Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 5.6% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health (HIMS) provides telehealth services and wellness products in the healthcare industry, experiencing a notable bearish movement in the stock market today.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 5.6% on Jan 30, 2026 17:00

• Unusual options activity reflecting a bearish sentiment and a wide price range target may suggest investor uncertainty and potential downward pressure on the stock.
• The recent decline in share price, combined with concerns over valuation, potentially influenced the bearish movement as investors reevaluate the stock's intrinsic value and relative overvaluation.
• The termination of a partnership with Novo Nordisk affecting drug access, the shift towards compounded alternatives, and other growth challenges could have prompted investor concerns about the company's future prospects, contributing to the bearish trend.
• An increase in short interest, indicating a more bearish sentiment and higher than average short positions, likely intensified selling pressure on the stock and exacerbated the downward trend.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Looking At Hims & Hers Health's Recent Unusual Options Activity

Benzinga's options scanner detected 14 uncommon options trades for Hims & Hers Health (NYSE: HIMS), with a sentiment split between 35% bullish and 50% bearish among large investors. These trades suggest that "whales" are targeting a price range of $30.0 to $100.0 for HIMS over the next three months. The article highlights significant call and put activities and provides an overview of Hims & Hers Health's business model and current market status.

https://www.sahmcapital.com/news/content/looking-at-hims-hers-healths-recent-unusual-options-activity-2026-01-27

Is It Too Early To Reconsider Hims & Hers Health (HIMS) After Recent Share Price Pullback?

Hims & Hers Health (HIMS) has experienced recent share price declines, prompting a valuation analysis. A Discounted Cash Flow (DCF) model suggests the stock is undervalued by 53.3%, with an intrinsic value of $63.39 compared to its current price of $29.62. However, its Price-to-Earnings (P/E) ratio of 50.40x appears overvalued when compared to the Healthcare industry average and Simply Wall St's Fair Ratio of 27.16x.

https://www.sahmcapital.com/news/content/is-it-too-early-to-reconsider-hims-hers-health-hims-after-recent-share-price-pullback-2026-01-24

Peering Into Hims & Hers Health Inc's Recent Short Interest

Hims & Hers Health Inc (NYSE: HIMS) has seen a 3.52% increase in its short interest, with 67.10 million shares now sold short, representing 36.46% of its float. This rise indicates a more bearish sentiment among investors, and the company's short interest is significantly higher than its peer group average of 8.15%. It would take traders an average of 6.19 days to cover their short positions.

https://www.sahmcapital.com/news/content/peering-into-hims-hers-health-incs-recent-short-interest-2026-01-23

End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health (HIMS)

Hims & Hers Health recently ended its partnership with Novo Nordisk, impacting its access to branded GLP-1 weight-loss drugs and shifting its focus to compounded alternatives amidst regulatory and margin challenges. This move, coupled with slowing growth predictions and increased telehealth competition, has prompted analysts and investors to re-evaluate the company's future growth drivers and investment narrative. The article suggests this makes Hims & Hers Health's stock more of a "show-me" situation as the company navigates these changes and relies on other initiatives for growth.

https://www.sahmcapital.com/news/content/end-of-novo-nordisk-glp-1-deal-could-be-a-game-changer-for-hims-hers-health-hims-2026-01-23

Trending Today

Alaska Air Group Inc. ($ALK) Stock Forecast: Down 5.6% Today

Roku Inc. ($ROKU) Stock Forecast: Down 5.3% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.4% Today

Apache Corporation ($APA) Stock Forecast: Down 5.4% Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Reddit Inc ($RDDT) Stock Forecast: Down 5.1% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Down 5.5% Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Down 5.1% Today

AT&T Inc. ($T) Stock Forecast: Up 5.0% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Down 5.1% Today

Hims & Hers Health Inc. Price History

17.10.2025 - HIMS Stock was down 5.4%

• The rollout of Labs accompanied by yearly plans for comprehensive testing from Hims & Hers Health (NYSE: HIMS) potentially generated optimistic investor attention and sentiment.
• However, the decline in stock price could be linked to competitive activities overshadowing the company's positive disclosures, raising potential investor apprehensions.
• Despite Hims & Hers expanding its technology-driven healthcare model with new services, selling pressure and market dynamics may have contributed to the stock's downward trajectory.
• Investor sentiment towards HIMS appears to be influenced by both company-specific updates and broader market conditions, leading to the observed bearish movement today.

21.00.2026 - HIMS Stock was down 5.4%

• The decline in HIMS stock today might be linked to investors taking profits following a period of growth, resulting in a temporary drop in the stock price.
• Despite the company's ambitious expansion strategies and revenue forecasts, investor apprehension about potential regulatory scrutiny and competition in the GLP-1 weight-loss sector may have adversely affected the stock price.
• The uncertainties surrounding HIMS' ability to effectively address these challenges and meet its revenue and earnings targets by 2028 could have contributed to investors' pessimistic outlook, causing a decrease in the stock price.

12.00.2026 - HIMS Stock was up 6.5%

• The bullish movement in HIMS stock today could be attributed to:
• Positive long-term outlook despite weak nearand mid-term sentiment.
• Trading systems reacting to the stock's volatility, potentially driving increased buying interest.
• The AI models generating multiple trading strategies to manage the current breakdown and downside risk.
• Investors might be optimistic about the company's future growth prospects and the potential of its telehealth and wellness products, leading to increased buying pressure and driving the stock price higher.

13.10.2025 - HIMS Stock was down 5.5%

• HIMS' ongoing global expansion of AI-driven personalized and subscription-based care, supported by recent funding, indicates a promising growth trajectory.
• Despite these positive developments, market sentiment turned bearish, possibly reflecting concerns regarding the scalability and profitability of new offerings in GLP-1 weight loss, hormone health, and custom treatments.
• Investor caution might stem from doubts about the company's ability to effectively monetize its technology-driven care model in the competitive healthcare sector, contributing to today's bearish stock movement.

23.11.2025 - HIMS Stock was down 5.0%

• The stock analysis for HIMS suggests weak near and mid-term sentiment despite a positive long-term outlook.
• AI-generated trading strategies indicate elevated downside risk, particularly due to a lack of additional long-term support signals.
• The market movement could be attributed to investors reacting to the increased risk levels and lack of near-term positive catalysts for the company.
• Overall, the bearish movement in HIMS today may be a result of the cautious sentiment surrounding the stock's short to mid-term prospects, as highlighted in the analysis.

20.10.2025 - HIMS Stock was down 5.7%

• The stock faced selling pressure, resulting in a decrease in value.
• Despite launching new services such as Labs for comprehensive testing, external factors may have overshadowed positive developments.
• Investor comparisons with other stocks like OMCL could have contributed to the bearish trend.
• Market dynamics and general investor sentiment towards telehealth and wellness firms likely influenced today's decline in the stock price.

30.00.2026 - HIMS Stock was down 5.6%

• Unusual options activity reflecting a bearish sentiment and a wide price range target may suggest investor uncertainty and potential downward pressure on the stock.
• The recent decline in share price, combined with concerns over valuation, potentially influenced the bearish movement as investors reevaluate the stock's intrinsic value and relative overvaluation.
• The termination of a partnership with Novo Nordisk affecting drug access, the shift towards compounded alternatives, and other growth challenges could have prompted investor concerns about the company's future prospects, contributing to the bearish trend.
• An increase in short interest, indicating a more bearish sentiment and higher than average short positions, likely intensified selling pressure on the stock and exacerbated the downward trend.

27.00.2026 - HIMS Stock was down 5.2%

• Short interest rose by 3.52% to 67.10 million shares, indicating a growing bearish sentiment among investors and putting downward pressure on the stock price.
• The termination of the partnership with Novo Nordisk, loss of access to branded drugs, and transition to compounded alternatives have raised concerns about future growth prospects, leading investors to reassess the company's potential.
• The CFO's sale of $275k in HIMS stock, amid worries about revenue growth and competition from Amazon Pharmacy, may have intensified negative sentiment among investors.
• In summary, regulatory hurdles, strategic changes, and competitive challenges likely contributed to the decline in Hims & Hers Health's stock today.

21.10.2025 - HIMS Stock was down 6.9%

• The optimism from significant investors towards Hims & Hers Health did not result in a rise in the stock's value, with noticeable selling pressure impacting its performance.
• Despite launching new health testing services through Labs with annual plans, HIMS shares declined, potentially due to external competitive factors influencing investor confidence.
• The market shift may be linked to increased selling activity, signaling a change in market dynamics despite favorable company updates.
• A comparison with another company's stock (OMCL vs. HIMS) implies that investors could be reconsidering their positions in HIMS, contributing to the bearish trend witnessed today.

22.00.2026 - HIMS Stock was up 5.7%

• The recent sale of $275k in HIMS stock by the company's CFO, Oluyemi Okupe, initially sparked concerns among investors.
• Despite worries regarding revenue growth and competition from Amazon Pharmacy, the market sentiment turned positive, potentially influenced by undisclosed positive factors.
• It is possible that the market interpreted the CFO's stock sale as a routine aspect of financial management rather than a signal of internal company issues.
• Investors may be placing emphasis on potential growth opportunities and strategic decisions by Hims & Hers Health, contributing to the bullish market performance.

22.00.2026 - HIMS Stock was up 5.5%

• The bullish movement in HIMS stock today could be attributed to the confidence shown by the CFO, Oluyemi Okupe, who sold a significant amount of stock but also exercised options to acquire shares, indicating a belief in the company's future performance.
• The concerns raised by analysts about revenue growth and competition from Amazon Pharmacy might have initially caused some uncertainty in the market, but Okupe's actions could have reassured investors about the company's prospects.
• Overall, Okupe's strategic move of selling and acquiring shares, coupled with the ongoing competition in the telehealth industry, likely contributed to the positive market sentiment and bullish movement in HIMS stock today.

10.11.2025 - HIMS Stock was down 5.4%

• The bearish movement in HIMS stock today could be attributed to the securities fraud class action lawsuit filed against the company. The allegations of deceptive promotion of illegitimate versions of Wegovy, jeopardizing its collaboration with Novo Nordisk, have raised concerns among investors.
• The negative news about the lawsuit may have led to a loss of investor confidence in Hims & Hers Health Inc., resulting in a significant downward pressure on the stock price.
• Investors are likely reacting to the potential risks associated with the allegations, causing a sell-off of HIMS shares as they reassess the company's credibility and future prospects in the telehealth industry.